Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
5 hedge funds and large institutions have $50K invested in Genetic Technologies Ltd. in 2013 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
29% less funds holding
Funds holding: 7 → 5 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
69% less capital invested
Capital invested by funds: $160K → $50K (-$110K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$19.3K |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$744 |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$186 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Aperio Group
Sausalito,
California
|
-$55K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$26K |
| 3 |
APU
Alpine Partners USVI
St. Thomas,
U.S. Virgin Islands
|
-$18.6K |
| 4 |
U
UBS
Zurich,
Switzerland
|
-$1K |
| 5 |
Citigroup
New York
|
-$186 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VKH
1
Virtu KCG Holdings
New York
| $31K | +$19.3K | +104 | +96% |
|
|
APU
2
Alpine Partners USVI
St. Thomas,
U.S. Virgin Islands
| $16K | -$18.6K | -100 | -47% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $2K | +$186 | +1 | +7% |
|
|
4
Group One Trading
Chicago,
Illinois
| $1K | +$744 | +4 | New |
|
|
AG
5
Aperio Group
Sausalito,
California
| – | -$55K | -238 | Closed |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$26K | -114 | Closed |
|
|
U
7
UBS
Zurich,
Switzerland
| – | -$1K | -6 | Closed |
|
|
8
Citigroup
New York
| – | -$186 | -1 | -25% |
|
GENE Hedge Fund Activity: Q4 2013 in Review
5 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q4 2013, worth a combined $50K — down 69% from $160K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of GENE and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Virtu KCG Holdings, adding an estimated $19.3K. The largest seller was Aperio Group, exiting entirely with an estimated $55K sold.
- 5 institutional investors held Genetic Technologies Ltd. (GENE) as of Q4 2013, down from 7 in Q3 2013.
- Funds reported $50K of Genetic Technologies Ltd. stock for Q4 2013, down 69% quarter-over-quarter.
- 1 fund opened new Genetic Technologies Ltd. positions in Q4 2013 and 3 closed out, a net change of -2 holders.
- The largest Genetic Technologies Ltd. buyer in Q4 2013 was Virtu KCG Holdings, an estimated $19.3K added.
- The largest Genetic Technologies Ltd. seller in Q4 2013 was Aperio Group, an estimated $55K sold.
Based on aggregated 13F filings for Q4 2013.